Chris Ahern retweeted
A club none of us ever wanted to join yet here we are. Fighting hard every day for a better future.
#cureSCN2A
Chris Ahern retweeted
This #preprint by @GraceGalles, @chrisahern and colleagues at @OregonState, @UofIllinois and @uiowa has recently been reviewed by @BiophysicsColab
You can read the report here:
sciety.org/articles/activity…
biorxiv.org/content/10.1101/…
Chris Ahern retweeted
Yet another company focused on #tRNA therapies launched yesterday: hC Bioscience, with $24 million and Craig Mello on the SAB. It is a good time to revisit the deep dive I wrote on this emerging tRNA technology back in Sept. cen.acs.org/pharmaceuticals/…
Chris Ahern retweeted
Ryan Hibbs, Associate Professor at UTSW and @ucsdbms @UCSDPharm alumnus, is presenting the Chemistry and Biochemistry seminar this Friday 👇
Fantastic news - major congrats to Leah and the SCN2A Foundation
This is an incredible opportunity for us to advance our mission! We are incredibly grateful to @ChanZuckerberg
#cureSCN2A
Chris Ahern retweeted
7.5 years ago I started the very first #SCN2A support group. We have grown to almost 1,000 families from around the globe! Happy 6th birthday
@FamilieSCN2A!
"On the eve of the Foundation's 6th birthday I reflect back on the day I started the Facebook support group. I knew was that there had to be other parents out there dealing with this diagnosis and I wanted to talk to them.” @LeahEDSCN2A #SCN2A
Chris Ahern retweeted
Happy birthday to #LaskerLaureate Bertil Hille! Hille was recognized for his work on #ionchannels, which govern the electrical potential of membranes, generating nerve impulses and controlling muscle contraction, cardiac rhythm, and hormone secretion. ow.ly/SPfX30lRPuy
Chris Ahern retweeted
For another perspective on C-type inactivation. Check out this JGP paper from @BenoitRoux6 and @eperozo_ rupress.org/jgp/article/150/…
Chris Ahern retweeted
Wow! Another structure of C-type inactivated state of Shaker type channel. Congrats to Francis Valiyaveetil and the team!
This Post is from an account that no longer exists. Learn more
Chris Ahern retweeted
Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy
ow.ly/nGGI50GlgOv
Slow inactivation is renewed! Great to see these open/inactivated structures along with the Shaker W434F from @kenton_swartz biorxiv.org/content/10.1101/…
@indolenitrogen
This Post is from an account that no longer exists. Learn more
Chris Ahern retweeted
Such promising work!
@TevardB @chrisahern
How @TevardB is using suppressor tRNA therapies to blow through the "stop signs" in instances of premature stop codons to enable appropriate translation of proteins. cen.acs.org/pharmaceuticals/…
Chris Ahern retweeted
Want to learn more about Voltage-Gated Sodium Channels #ionchannels? Join us on Sept. 28, 2021, with the inaugural seminar by Dr. Nieng Yan @NiengYan "Close a voltage-gated sodium channel by a door wedge" - more info on sodiumchannelseminars.org/ co-organized @LampertLabRWTH & us.
Chris Ahern retweeted
Exciting times for @KelleyLabs!
Shana Kelley, a pioneer in translational bioanalytical research, and Ted Sargent, a renowned researcher in nanotechnology, join Northwestern. @WeinbergCollege @NUChemistry @NorthwesternEng @IINanoNU @NorthwesternU Learn more: wcas.nu/3zeyCnc
Chris Ahern retweeted
Hyde Park is glowing 🌆
📷 @brettbeyer
Chris Ahern retweeted
Join us Sept. 30 for next webinar presented by Dr. Ishmail Abdus-Saboor, Asst Prof at @Columbia. He'll discuss findings from efforts to uncover a behavioral map of sensory-vs-motivational pain in mice. #drugdiscovery #translationalresearch #painresearch
attendee.gotowebinar.com/reg…
Chris Ahern retweeted
On behalf of twitter-less Dr. Dave MacLean: the MacLean Lab at @urochestermed is looking for a postdoctoral candidate! Attached is a letter with more info. TL;DR talented scientists with backgrounds in genetic code expansion, ephys and/or fluorescence techniques should apply!



























